Scientific Board
Striving to make a difference
Our customers operate in the front lines of the biomedical sciences. To offer them the best possible service and to be able to respond to the latest developments it is important to have a sounding board within the different disciplines of Biomedical Sciences. Our Scientific Advisory Board, consisting of leading scientists, signals the developments and gives us solicited and unsolicited advice. This way we remain up-to-date and state-of-the-art in helping you with our services and innovative solutions to bring your research further.
Our Scientific Advisory Board consists of:
Prof. Dr. Alain de Bruin
Oncology, Veterinary Pathology / Affiliation: University of Utrecht
Alain de Bruin’s group is interested in the molecular mechanisms that control cell proliferation in normal cells and in cancer cells. The group wants to understand how E2F transcription factors mediate the appropriate control of the cell cycle entry and exit that is required for normal development and tumour suppression. Read more>>
Prof. Dr. Esther Wolfs
Imaging, Cancer, and Charcot-Marie-Tooth Disease / Affiliation: BIOMED research institute, Hasselt University
The lab houses several in vitro assays (co-cultures, 3D cultures and myelination assays) and in vivo disease models (cancer models and CMT1A).
Marije Slingerland, MD PhD
Medical Oncology / Affiliation: Leiden University Medical Center
Dr. Luuk Hawinkels
Cell-cell Interactions, Gastrointestinal Diseases / Affiliation: Leiden University Medical Center
AAALAC Accreditation
InnoSer has earned the AAALAC accreditation, demonstrating our commitment to responsible animal care and use. AAALAC International is a nonprofit organization that promotes the humane treatment of animals in science through voluntary accreditation and assessment programs. Our accreditation is valid for three years, incl. 2023. Read more about the AAALAC accreditation programme here.
Animal Welfare
The 3Rs impact everything from policy and regulatory change to the development and uptake of new technologies and approaches. This is why InnoSer has ongoing commitment and monitoring of these processes. The steps we practice maximize our ability to replace, reduce and refine animal involvement and facilitate our commitment to these principles when it comes to research and drug development.
info@innoserlaboratories.com